Consolidated Statements of Operations - USD ($) |
3 Months Ended | 6 Months Ended | 12 Months Ended | |||
|---|---|---|---|---|---|---|
Jun. 30, 2025 |
Jun. 30, 2024 |
Jun. 30, 2025 |
Jun. 30, 2024 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|
| Income Statement [Abstract] | ||||||
| Revenue | $ 1,845,334 | $ 4,037,535 | $ 3,777,686 | $ 8,088,334 | $ 15,242,560 | $ 17,562,903 |
| Operating Expenses: | ||||||
| Compensation and employee benefits | 1,583,051 | 2,264,931 | 2,955,532 | 4,544,969 | 7,783,331 | 10,334,212 |
| General and administrative expenses | 457,803 | 1,001,764 | 1,448,629 | 1,985,984 | 4,018,094 | 6,587,392 |
| Professional services | 712,337 | 503,727 | 2,211,871 | 964,677 | 2,518,394 | 1,858,137 |
| Lease expense | 258,477 | 315,614 | ||||
| Credit loss (benefit) expense | (1,393,131) | 290,857 | ||||
| Impairment of goodwill | 0 | 0 | 0 | 0 | 6,058,000 | 13,208,276 |
| Impairment of long-lived intangible assets | 3,090,881 | 5,699,464 | ||||
| Rent expense | 63,185 | 64,198 | 124,191 | 133,635 | ||
| Provision (benefit) for credit losses | (97,248) | (166,035) | ||||
| Total operating expenses | 2,816,376 | 3,737,372 | 6,740,223 | 7,463,230 | 22,334,046 | 38,293,952 |
| Operating (loss) income | (971,042) | 300,163 | (2,962,537) | 625,104 | (7,091,486) | (20,731,049) |
| Other Income (Expenses) | ||||||
| Interest expense | 115,341 | 168,830 | 228,127 | 323,002 | 533,390 | 1,094,736 |
| Change in fair value of warrant liabilities | 138,158 | 1,086,286 | 1,254,240 | 2,341,773 | 2,803,638 | (1,853,920) |
| Change in the fair value of deferred consideration | (40,960) | 211,535 | 120,040 | 396,070 | 361,449 | 4,570,157 |
| Total other income (expenses) | (18,143) | 1,128,991 | 1,146,153 | 2,414,841 | 2,631,697 | 1,621,501 |
| Net (loss) income before income tax | (989,185) | 1,429,154 | (1,816,384) | 3,039,945 | (4,459,789) | (19,109,548) |
| Income tax benefit/(expense) | (58,470) | 487,627 | (58,470) | 48,742 | 43,859,686 | (1,829,701) |
| Net (loss) income | $ (930,715) | $ 941,527 | $ (1,757,914) | $ 2,991,203 | $ (48,319,475) | $ (17,279,847) |
| Weighted average shares outstanding, basic | 2,826,468 | 2,771,550 | 2,806,841 | 2,766,086 | 2,772,867 | 2,128,728 |
| Basic net (loss) income per share | $ (0.33) | $ 0.34 | $ (0.63) | $ 1.08 | $ (17.43) | $ (8.12) |
| Weighted average shares outstanding, diluted | 2,826,468 | 2,824,273 | 2,806,841 | 2,818,809 | 2,772,867 | 2,128,728 |
| Diluted (loss) income per share | $ (0.33) | $ 0.33 | $ (0.63) | $ 1.06 | $ (17.43) | $ (8.12) |
| X | ||||||||||
- Definition Change in fair value of deferred consideration. No definition available.
|
| X | ||||||||||
- Definition Change in fair value of warrant liabilities. No definition available.
|
| X | ||||||||||
- Definition Credit loss benefit expense. No definition available.
|
| X | ||||||||||
- Definition Rent expense. No definition available.
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of expense for employee benefit and equity-based compensation. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of impairment loss from asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of interest expense classified as nonoperating. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of operating lease expense. Excludes sublease income. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of expense (reversal of expense) for expected credit loss on accounts receivable. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|